Compare
5 stocks, side by sideRelative performance · rebased to 100
RLAYDNLIRCUSACADNAMS
| RLAYRelay Therapeutics, Inc. | DNLIDenali Therapeutics Inc. | RCUSArcus Biosciences, Inc. | ACADACADIA Pharmaceuticals Inc. | NAMSNewAmsterdam Pharma Company N.V. | |
|---|---|---|---|---|---|
| Smart Score | 7/10 | 2/10 | 6/10 | 6/10 | 3/10 |
| Price | $19.09 | $22.08 | $29.02 | $27.58 | $25.66 |
| 1 month | -3.1% | -11% | +2.2% | -3.1% | -7.1% |
| 1 year | +450% | +49% | +177% | +10% | +1.0% |
| 5 year | -42% | -58% | +5.8% | +50% | +165% |
| P/E (TTM) | -12.2 | -7.7 | -9.2 | 12.5 | -14.4 |
| P/E vs sector | - | - | - | -58% | - |
| Market cap | $3.9B | $3.9B | $3.8B | $4.1B | $3.7B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.